These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28232661)

  • 1. Personalized Analysis by Validation of Monte Carlo for Application of Pathways in Cardioembolic Stroke.
    Xing Z; Luan B; Zhao R; Li Z; Sun G
    Med Sci Monit; 2017 Feb; 23():994-1000. PubMed ID: 28232661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Dysregulated Networks in Individual Patients with Ischemic Stroke Based on Monte Carlo Cross-Validation.
    Sun G; Luan B; Zhao R; Li Z; Xing Z
    DNA Cell Biol; 2016 Dec; 35(12):795-801. PubMed ID: 27726417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease.
    Li T; Tang W; Zhang L
    Neurol Sci; 2016 Aug; 37(8):1327-33. PubMed ID: 27146810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating differential pathway analysis with Monte Carlo cross-validation reveals seed cross-talks in non-small cell lung carcinoma.
    Zheng ML; Zhou NK; Luo CH
    J BUON; 2016; 21(5):1203-1209. PubMed ID: 27837624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel targets for multiple myeloma through integrative approach with Monte Carlo cross-validation analysis.
    Liu C; Gu X; Jiang Z
    J Bone Oncol; 2017 Sep; 8():8-12. PubMed ID: 28856086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting pathway cross-talks in ankylosing spondylitis through investigating the interactions among pathways.
    Gu X; Liu CJ; Wei JJ
    Braz J Med Biol Res; 2017 Nov; 51(1):e6698. PubMed ID: 29160414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for ischemic stroke subtypes: A protein-protein interaction analysis.
    Wei LK; Quan LS
    Comput Biol Chem; 2019 Dec; 83():107116. PubMed ID: 31561071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of significant pathway cross-talk in rheumatoid arthritis by the Monte Carlo cross-validation method.
    Song W; Zhang YM; Ma T; Wang J; Wang KZ
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Monte Carlo cross-validation to identify pathway cross-talk in neonatal sepsis.
    Zhang Y; Liu C; Wang J; Li X
    Exp Biol Med (Maywood); 2018 Mar; 243(5):444-450. PubMed ID: 29513099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network analysis of HBV‑ and HCV‑induced hepatocellular carcinoma based on Random Forest and Monte Carlo cross‑validation.
    Zhao SN; Liu LL; Lv ZP; Wang XH; Wang CH
    Mol Med Rep; 2017 Sep; 16(3):2411-2416. PubMed ID: 28656273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
    Colaprico A; Cava C; Bertoli G; Bontempi G; Castiglioni I
    Biomed Res Int; 2015; 2015():831314. PubMed ID: 26240829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway analysis based on Monte Carlo Cross-Validation in polyarticular juvenile idiopathic arthritis.
    Lin S; Wang Y; Mu S; Zhang J; Yuan F; Sun K
    Pathol Res Pract; 2017 Jan; 213(1):7-12. PubMed ID: 27894617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: A preliminary study.
    Zheng ML; Zhou NK; Luo CH
    Microb Pathog; 2016 Nov; 100():78-83. PubMed ID: 27616444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized discovery of altered pathways in clear cell renal cell carcinoma using accumulated normal sample data.
    Wang X; Ding M; Yang Y; Feng Y; Shi Z; Qiu F; Zhu M
    J BUON; 2016; 21(2):390-8. PubMed ID: 27273949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of network-based biomarkers of cardioembolic stroke using a systems biology approach with time series data.
    Wong YH; Wu CC; Lai HY; Jheng BR; Weng HY; Chang TH; Chen BS
    BMC Syst Biol; 2015; 9 Suppl 6(Suppl 6):S4. PubMed ID: 26679092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling.
    Barr TL; Conley Y; Ding J; Dillman A; Warach S; Singleton A; Matarin M
    Neurology; 2010 Sep; 75(11):1009-14. PubMed ID: 20837969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of biomarkers in stroke based on ego-networks and pathways.
    Li H; Guo Q
    Biotechnol Lett; 2017 Dec; 39(12):1835-1842. PubMed ID: 28875412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum uric acid and cardioembolic stroke in patients with acute ischemic stroke.
    Yang XL; Kim Y; Kim TJ; Jung S; Kim CK; Lee SH
    J Neurol Sci; 2016 Nov; 370():57-62. PubMed ID: 27772788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes.
    Henninger N; Goddeau RP; Karmarkar A; Helenius J; McManus DD
    Stroke; 2016 Jun; 47(6):1486-92. PubMed ID: 27217503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in the prognostic significance of N-terminal pro-B-type natriuretic peptide between cardioembolic and noncardioembolic ischemic strokes.
    Lee SJ; Lee DG; Lim DS; Hong S; Park JS
    Dis Markers; 2015; 2015():597570. PubMed ID: 25834300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.